WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

This group comprises all hormonal preparations for systemic use, except:

- Insulins, see A10.
- Anabolic steroids, see A14.
- Catecholamines, see C01C and R03C.
- Sex hormones, see G03.
- Sex hormones used in treatment of neoplastic diseases, see L02.

The DDDs are generally based on the treatment or diagnosis of endocrine disorders.


H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
H01C HYPOTHALAMIC HORMONES

This group comprises hypothalamic hormones; extracts, purified natural hormones and synthetic analogues.

Hypothalamic hormones used as diagnostic agents for pituitary function are classified in V04CD.


H01CB Somatostatin and analogues

Somatostatin, octreotide and lanreotide, which are also used in cancer, are classified in this group.

The DDDs of octreotide and lanreotide are based on the treatment of acromegaly.


    ATC code  Name  DDD  U Adm.R Note
    H01CB05  pasireotide 1.2 mg 

List of abbreviations

Last updated: 2013-12-19